<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> WSJ870312-0166 </DOCNO><HL> Integrated Genetics' Hormone</HL><DD> 03/12/87</DD><SO> WALL STREET JOURNAL (J)</SO><IN> INGNPHARMACEUTICALS, HOSPITAL SUPPLIES, MANAGEMENT (PHA)FOOD AND DRUG ADMINISTRATION (FDA) </IN><DATELINE> FRAMINGHAM, Mass.  </DATELINE><TEXT>   Integrated Genetics Inc. said the Food and Drug Administration approved the start of field trials of its bovine follicle stimulating hormone, a protein that regulates reproduction in cows.    The first application of the hormone will be to induce ovulation in genetically superior cows so their eggs can be harvested, fertilized in test tubes and implanted in bovine surrogate mothers.    In national over-the-counter trading yesterday, Integrated Genetics shares closed at $12.375, up 37.5 cents. </TEXT></DOC>